Pharmaceutical

Oncology biosimilar case studies: rituximab biosimilars

The first approved biosimilar in the US and EU was Celltrion/Teva Pharmaceutical...

OncoResponse receives CPRIT grant to advance OR502

OR2805 was discovered using the company’s B cells discovery platform.

SiteOne secures funding from NIDA for non-opioid therap...

The grant is a UG3/UH3 phase innovation awards co-operative agreement in two pha...

Alimera Sciences buys US rights to EyePoint’s Yutiq

Yutiq received the US Food and Drug Administration's approval in October 2018.

US FDA approves Bausch + Lomb and Novaliq’s DED treatm...

Miebo is the first and only prescription eye drop to receive approval from the F...

STAT+: In its first tough test, CRISPR epigenome editin...

The Tune Therapeutics results are the first published data showing successful CR...

STAT+: 1 in 5 primary endpoints changed in late-stage t...

The findings raised questions about the quality of the clinical trials, as well ...

STAT+: FDA advisers vote against approving Intercept’s ...

A panel of expert advisers to the FDA voted against approving Intercept Pharmace...

STAT+: FDA approves first treatment for skin condition ...

The FDA approved the first treatment for dystrophic epidermolysis bullosa, a dev...

STAT+: Novo Nordisk pauses ads for weight loss drug Weg...

The company behind the weight-loss-inducing drugs Ozempic and Wegovy is pausing ...

STAT+: FDA official offers insights into whether gene t...

The FDA is thinking about a groundbreaking approach to making gene therapies tha...

STAT+: Pear Therapeutics sold for parts at $6 million a...

Four companies agreed to buy the assets of Pear Therapeutics at auction after th...

STAT+: Pharmalittle: AstraZeneca plans to ‘love’ China’...

The U.S. Supreme Court upheld a ruling that Amgen failed to disclose sufficient ...

After decades of neglecting women athletes, sport and e...

Sports medicine has long neglected research on female athletes, putting them at ...

Opinion: Chelsea Clinton: How to eliminate viral hepati...

Viral hepatitis affects almost 400 million people and kills more than 1 million ...

Opinion: How I helped Pfizer think through the ethics o...

What it was like advising Pfizer on the ethics of Viagra in 1998.